ARHT Media Announces Closing of Second and Final Tranche of Private Placement of Secured Subordinated Debentures
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or the “Company”) (TSXV:ART), (OTCQB:ARHTF) the global leader in […]
Great American Cookies Has a Zest for Summer with All-New Lemon Cookie
Lemon Cookie, Blueberry Muffin Cookie and Strawberry Crinkle Cookie Make for Picnic Perfect Pairing LOS ANGELES, June 17, 2024 (GLOBE […]
LPL Financial Welcomes Russell Wealth Partners
SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq: LPLA) announced today that financial advisor Tom Russell, CFP®, […]
Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products
Beijing, June 17, 2024 (GLOBE NEWSWIRE) — Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic […]
NVIDIA Announces Omniverse Microservices to Supercharge Physical AI
SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) — CVPR—NVIDIA today announced NVIDIA Omniverse Cloud Sensor RTX™, a set of microservices that […]
Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
MIAMI, June 17, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular […]
PodcastOne (Nasdaq: PODC) Adds Tactful Pettiness Podcast to Its Network
– Hosted by Cody Rigsby and Andrew Chappelle – 8th New Podcast Joining PodcastOne Network This Fiscal Year, 39th In […]
iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer
WATERTOWN, Mass. and GOSSELIES, Belgium, June 17, 2024 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical […]
Sachem Capital Corp. Announces Registered Public Offering of Notes
BRANFORD, Conn., June 17, 2024 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) today announced the commencement of a […]
Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds
MIAMI, June 17, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology […]
